KURA

insider transactions

Kura Oncology, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-64.9K

0 buy · 64.9K sell

Net value · 90d

-$2.0M

$0 in · $2.0M out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 64.9K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 4, 26

Diane L. Parks

Director

$0

35.0K sh

Own New
Grant·A
Jun 4, 26

Michael Vasconcelles

Director

$0

35.0K sh

Own New
Grant·A
Jun 4, 26

Carol Schafer

Director

$0

35.0K sh

Own New
Grant·A
Jun 4, 26

Mary T Szela

Director

$0

35.0K sh

Own New
Grant·A
Jun 4, 26

Thomas Malley

Director

$0

35.0K sh

Own New
Grant·A
Jun 4, 26

Faheem Hasnain

Director

$0

35.0K sh

Own New
Grant·A
Jun 4, 26

Helen Louise Collins

Director

$0

35.0K sh

Own New
Sell·S
May 21, 26

Brian T. Powl

Chief Commercial Officer · 10b5-1

$110.0K

10.0K sh · $11.00

Own -5%
Sell·S
May 19, 26

Brian T. Powl

Chief Commercial Officer · 10b5-1

$3.1K

339 sh · $9.21

Own -0%
Sell·S
May 19, 26

Kathleen Ford

Chief Operating Officer · 10b5-1

$20.5K

2.3K sh · $9.08

Own -1%
Exercise·M
May 18, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$0

5.0K sh

Own +4%
Sell·S
May 18, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$9.2K

223 sh · $41.21

Own -1%
Sell·S
May 18, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$52.4K

1.3K sh · $40.25

Own -5%
Sell·S
May 18, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$137.4K

3.5K sh · $39.53

Own -12%
Exercise·M
May 18, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$12.4K

5.0K sh · $2.48

Own +20%
Sell·S
May 18, 26

Teresa Brophy Bair

Chief Legal Officer · 10b5-1

$21.2K

2.3K sh · $9.38

Own -1%
Exercise·M
Apr 17, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$0

5.0K sh

Own +4%
Sell·S
Apr 17, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$117.3K

2.4K sh · $48.06

Own -9%
Sell·S
Apr 17, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$114.6K

2.4K sh · $47.39

Own -8%
Sell·S
Apr 17, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$6.4K

140 sh · $45.81

Own -0%
Exercise·M
Apr 17, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$12.4K

5.0K sh · $2.48

Own +20%
Exercise·M
Mar 25, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$0

40.0K sh

Own +42%
Sell·S
Mar 25, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$1.4M

40.0K sh · $35.10

Own -62%
Exercise·M
Mar 25, 26

Helen Louise Collins

CHIEF MEDICAL OFFICER · 10b5-1

$99.2K

40.0K sh · $2.48

Own +160%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 4, 2026	Diane L. Parks	Director	Grant A	35.0K	New	—	$0
Jun 4, 2026	Michael Vasconcelles	Director	Grant A	35.0K	New	—	$0
Jun 4, 2026	Carol Schafer	Director	Grant A	35.0K	New	—	$0
Jun 4, 2026	Mary T Szela	Director	Grant A	35.0K	New	—	$0
Jun 4, 2026	Thomas Malley	Director	Grant A	35.0K	New	—	$0
Jun 4, 2026	Faheem Hasnain	Director	Grant A	35.0K	New	—	$0
Jun 4, 2026	Helen Louise Collins	Director	Grant A	35.0K	New	—	$0
May 21, 2026	Brian T. Powl 10b5-1	Chief Commercial Officer	Sell S	10.0K	-5%	$11.00	$110.0K
May 19, 2026	Brian T. Powl 10b5-1	Chief Commercial Officer	Sell S	339	-0%	$9.21	$3.1K
May 19, 2026	Kathleen Ford 10b5-1	Chief Operating Officer	Sell S	2.3K	-1%	$9.08	$20.5K
May 18, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Exercise M	5.0K	+4%	—	$0
May 18, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	223	-1%	$41.21	$9.2K
May 18, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	1.3K	-5%	$40.25	$52.4K
May 18, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	3.5K	-12%	$39.53	$137.4K
May 18, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Exercise M	5.0K	+20%	$2.48	$12.4K
May 18, 2026	Teresa Brophy Bair 10b5-1	Chief Legal Officer	Sell S	2.3K	-1%	$9.38	$21.2K
Apr 17, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Exercise M	5.0K	+4%	—	$0
Apr 17, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	2.4K	-9%	$48.06	$117.3K
Apr 17, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	2.4K	-8%	$47.39	$114.6K
Apr 17, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	140	-0%	$45.81	$6.4K
Apr 17, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Exercise M	5.0K	+20%	$2.48	$12.4K
Mar 25, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Exercise M	40.0K	+42%	—	$0
Mar 25, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Sell S	40.0K	-62%	$35.10	$1.4M
Mar 25, 2026	Helen Louise Collins 10b5-1	CHIEF MEDICAL OFFICER	Exercise M	40.0K	+160%	$2.48	$99.2K

About KURA insider trading

This page tracks insider transactions for Kura Oncology, Inc. (KURA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.